The Latin America, Middle East and Africa Vitamin K2 Market would witness market growth of 15.7% CAGR during the forecast period (2024-2031).
The Brazil market dominated the LAMEA Vitamin K2 Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $6.72 millions by 2031. The Argentina market is showcasing a CAGR of 16.6% during (2024 - 2031). Additionally, The UAE market would register a CAGR of 15.3% during (2024 - 2031).
The primary causes of mortality worldwide are cardiovascular diseases (CVDs), which include stroke and heart disease. According to the World Health Organization (WHO), cardiovascular diseases are responsible for around 17.9 million fatalities annually, which together account for 31% of all deaths that occur worldwide.
Moreover, arterial calcification is a significant factor in the development of cardiovascular disease. Vitamin K2 has been shown to play a vital role in preventing arterial calcification. It activates matrix Gla-protein (MGP), which inhibits calcium from depositing in the arteries, thus maintaining arterial flexibility and health.
As economies in LAMEA countries develop, disposable income increases, leading to more spending on preventative healthcare and supplements. Rapid urbanization across LAMEA regions often leads to lifestyle changes, including increased processed food consumption and decreased physical activity. This can contribute to vitamin deficiencies, potentially driving demand for vitamin K2 supplements.
Based on Product Type, the market is segmented into MK-7 and MK-4. Based on Form, the market is segmented into Powder & Crystalline, Capsules & Tablets, and Oils & Liquid. Based on Application, the market is segmented into Health Supplements, Pharmaceutical, and Functional Food & Beverages. Based on Source, the market is segmented into Natural and Synthetic. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The Brazil market dominated the LAMEA Vitamin K2 Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $6.72 millions by 2031. The Argentina market is showcasing a CAGR of 16.6% during (2024 - 2031). Additionally, The UAE market would register a CAGR of 15.3% during (2024 - 2031).
The primary causes of mortality worldwide are cardiovascular diseases (CVDs), which include stroke and heart disease. According to the World Health Organization (WHO), cardiovascular diseases are responsible for around 17.9 million fatalities annually, which together account for 31% of all deaths that occur worldwide.
Moreover, arterial calcification is a significant factor in the development of cardiovascular disease. Vitamin K2 has been shown to play a vital role in preventing arterial calcification. It activates matrix Gla-protein (MGP), which inhibits calcium from depositing in the arteries, thus maintaining arterial flexibility and health.
As economies in LAMEA countries develop, disposable income increases, leading to more spending on preventative healthcare and supplements. Rapid urbanization across LAMEA regions often leads to lifestyle changes, including increased processed food consumption and decreased physical activity. This can contribute to vitamin deficiencies, potentially driving demand for vitamin K2 supplements.
Based on Product Type, the market is segmented into MK-7 and MK-4. Based on Form, the market is segmented into Powder & Crystalline, Capsules & Tablets, and Oils & Liquid. Based on Application, the market is segmented into Health Supplements, Pharmaceutical, and Functional Food & Beverages. Based on Source, the market is segmented into Natural and Synthetic. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
List of Key Companies Profiled
- Balchem Corporation
- Novozymes A/S (Novo Holdings A/S)
- BASF SE
- Lonza Group Ltd. (Capsugel)
- Haihang Industry Co.,Ltd. (Haihang Group)
- AngelYeast Co., Ltd.
- Kyowa Hakko USA, Inc.
- Lesaffre Group
- DSM Nutritional Products
- Herbalife International, Inc.
Market Report Segmentation
By Product Type- MK-7
- MK-4
- Powder & Crystalline
- Capsules & Tablets
- Oils & Liquid
- Health Supplements
- Pharmaceutical
- Functional Food & Beverages
- Natural
- Synthetic
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. LAMEA Vitamin K2 Market by Product Type
Chapter 5. LAMEA Vitamin K2 Market by Form
Chapter 6. LAMEA Vitamin K2 Market by Application
Chapter 7. LAMEA Vitamin K2 Market by Source
Chapter 8. LAMEA Vitamin K2 Market by Country
Chapter 9. Company Profiles
Companies Mentioned
- Balchem Corporation
- Novozymes A/S (Novo Holdings A/S)
- BASF SE
- Lonza Group Ltd. (Capsugel)
- Haihang Industry Co.,Ltd. (Haihang Group)
- AngelYeast Co., Ltd.
- Kyowa Hakko USA, Inc.
- Lesaffre Group
- DSM Nutritional Products
- Herbalife International, Inc.
Methodology
LOADING...
